Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-03-27
1991-08-06
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514213, 540522, 540523, 546204, A01N 4346, A61K 3155, C07D22316, C07D28110
Patent
active
050378210
ABSTRACT:
A method is provided for inhibiting loss of cognitive function, including memory, which may or may not be associated with Alzheimer's disease, in a mammalian species by administering a benzazepine-type or a pyrimidine-type calcium channel blocker such as diltiazem, SQ 31,765, SQ 32,324, SQ 33,351, SQ 33,537 or SQ 32,547 alone or in combination with an ACE inhibitor, such as captopril or SQ 29,852, over a prolonged period of treatment.
REFERENCES:
patent: 4694002 (1987-09-01), Floyd et al.
patent: 4696924 (1986-07-01), Marcoux
patent: 4748239 (1988-05-01), Floyd et al.
Qin, W. C. et al., Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao, Oct. 1986, 8 (5) pp. 366-370.
Albizzati, M. G., et al., "Cyclandelate Versus Fulnarizine, a Double-Blind Study in a Selected Group of Patients with Dementia", Drugs 1987, 33 Suppl. 2, 90-96.
Adler, L. et al., "Calcium Channel Antagonists in Tardive Dyskinesia and Psychosis".
Leyd, D. et al., "Diltiazem for Tardive Dyskinesia," The Lancet, Jan. 30, 1988.
Dolin, S. J. et al., "Calcium Channel Antagonists Decrease the Ethanol Withdrawal Syndrome," British Journal of Pharmacology, vol. 87, Mr. Suppl. 40P (1986).
Croog, S. H. et al., "The Effects of Antihypertensive Therapy on the Quality of Life," New England J. of Med. 314:1657-1664 (Jun. 26), 1986.
G. Spinosa et al., "Angiotensin Converting Enzyme Inhibitors: Animal Experiments Suggest a New Pharmacological Treatment for Alcohol Abuse in Humans," Alcoholism: Clinical and Experimental Research, vol. 12, No. 1, Jan./Feb. 1988, pp. 65-70.
Azpuru Carlos
Cashion Jr. Merrell C.
E. R. Squibb & Sons Inc.
Rodney Burton
LandOfFree
Method for inhibiting loss of cognitive functions employing a ca does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting loss of cognitive functions employing a ca, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting loss of cognitive functions employing a ca will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1987183